CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley,…
Author: Business Wire
Re-Vana Therapeutics Strengthens Executive Team with the Appointments of Michael Nash as Chief Commercial Officer and David Shima, PhD, as Vice President of R&D
BELFAST, Northern Ireland–(BUSINESS WIRE)–Re-Vana Therapeutics announced appointments of Michael Nash, Chief Commercial Officer, and David Shima, Vice President of Research and Development.
Invincible Vision and ReflectionBio Join Forces Ahead of World Rare Disease Day for Bietti’s Crystalline Dystrophy
SAN FRANCISCO & HONG KONG–(BUSINESS WIRE)– #BCD–There is new hope for BCD patients. Invincible Vision joins forces with ReflectionBio whose gene therapy research has shown promise.
Topcon Announces US Launch of the Harmony Glaucoma Module
OAKLAND, N.J.–(BUSINESS WIRE)– #Glaucoma–Topcon Healthcare announced today that it has launched its new Glaucoma Module feature for the Harmony Clinical Data Management Solution.
AIS Healthcare Goes Above and Beyond to Supply Critical Medication During Severe Winter Storm
DALLAS–(BUSINESS WIRE)–In the wake of a severe winter storm that has affected both the pharmaceutical supply chain as well as national shipping services, AIS Healthcare has gone above and beyond to ensure all of its patients have uninterrupted access…
Ophthalmic Drugs Market Size, Share & Trends Analysis Report 2021-2028: Strong Developmental Pipeline, Advancements In Drug Delivery, Promising Investment Scenario – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Drugs Market Size, Share & Trends Analysis Report by Disease (Dry Eye, Eye Allergy, Glaucoma, Eye Infection), by Drug Class, by Dosage Form, by Route Of Administration, by Product Type, by Region, and Segmen…
New Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Well Beyond Acute Disease into Chronic Phase
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics announced results of a new Thyroid Eye Disease (TED) quality of life assessment presented at the NANOS Annual Meeting.
Noveome Biotherapeutics, Inc. To Present At The 9th Annual Virtual Neurodegenerative Drug Development Summit
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc. To Present At The 9th Annual Virtual Neurodegenerative Drug Development Summit
Resolve Biosciences Announces Initial Results from Early Access Collaborations with Scientists Leading the Next Generation of Subcellular Spatial Analysis
MONHEIM AM RHEIN, Germany–(BUSINESS WIRE)– #COVID19–Resolve Biosciences announced initial results from several prominent early access collaborations with leading laboratories across Europe.
Aerie Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Worldwide Assistive Technologies For Visually Impaired Market to 2028 – Mobility Devices Will be the Fastest Growing Segment – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Assistive Technologies For Visually Impaired Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2020 To 2028” report has been added to Resea…
2021 Pipeline Insights on the Inflammation and Pain Post Cataract Surgery Industry – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Inflammation and Pain Post Cataract Surgery – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about 5+ companies and 5+ pipeline drugs…
Gemini Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD) and linked ocular disorders, today …
Global Eye Health Supplements Market Trajectory & Analytics Report Featuring Alliance Pharma, Amway, Novartis, Pfizer, The Nature's Bounty, Valeant Pharmaceuticals & Vitabiotics – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eye Health Supplements – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Eye Health Supplements Market to Reach $108.4 Million by 2027 Amid the COVID-19 crisis, …
Global Ophthalmic Loupes Market (2020 to 2027) – Share, Size, Trends, Industry Analysis Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Loupes Market Share, Size, Trends, Industry Analysis Report, By Loupe Type; By Design; By End-Use; By Regions – Segment Forecast, 2020-2027” report has been added to ResearchAndMarkets.com’s offering. The global…
Asia Pacific Eye Health Supplement Market Forecast to 2027: Analysis by Ingredient type; Indication, Cataract, Dry Eye syndrome, Others; and Form, and Countries – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Eye Health Supplement Market Forecast to 2027 – COVID-19 Impact and Regional Analysis by Ingredient type; Indication, Cataract, Dry Eye syndrome, Others; and Form, and Countries” report has been added to Resea…
Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S.
GENEVA–(BUSINESS WIRE)–Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S.
Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S.
GENEVA–(BUSINESS WIRE)–Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S.
Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report fo…
Ashvattha Therapeutics Announces Attendance at Upcoming Investor Conferences
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Ashvattha Therapeutics Announces Attendance at Upcoming Investor Conferences